Table 2.
Number of symptoms per cancer site that occurred in more than 1% and 50% of cases.
| Cancer Site | N | % with at least one recorded symptom (95% CI) | Number of symptoms with frequency > 1% by cancer site cohort | Number of symptoms with frequency > 50% by cancer site cohort |
|---|---|---|---|---|
| Head and neck | ||||
| Larynx | 368 | 91.8 (88.6, 94.2) | 13 | 1 (hoarseness) |
| Oral cavity | 585 | 70.6 (66.8, 74.1) | 12 | 0 |
| Oropharynx | 653 | 92.2 (89.9, 94.0) | 12 | 0 |
| Thyroid | 633 | 73.6 (70.0, 76.9) | 11 | 0 |
| Other head and neck | 481 | 88.6 (85.4, 91.1) | 15 | 0 |
| Upper gastrointestinal | ||||
| Oesophagus | 1391 | 89.8 (88.1, 91.3) | 21 | 0 |
| Stomach | 1029 | 84.6 (82.3, 86.7) | 23 | 0 |
| Lower gastrointestinal | ||||
| Anal | 265 | 91.3 (87.3, 94.1) | 16 | 1 (rectal bleeding) |
| Colon | 4209 | 80.0 (78.7, 81.2) | 17 | 0 |
| Rectum | 1641 | 88.8 (87.2, 90.3) | 15 | 1 (rectal bleeding) |
| Small intestine | 256 | 77.7 (72.2, 82.4) | 21 | 0 |
| Hepato-pancreato-biliary (HPB) | ||||
| Liver | 929 | 64.4 (61.2, 67.4) | 21 | 0 |
| Pancreas | 1725 | 84.8 (83.0, 86.4) | 23 | 0 |
| Other HPB | 425 | 81.9 (77.9, 85.3) | 20 | 0 |
| Respiratory | ||||
| Lung | 7608 | 76.4 (75.4, 77.3) | 17 | 0 |
| Mesothelioma | 464 | 87.5 (84.2, 90.2) | 15 | 0 |
| Urological | ||||
| Bladder | 1518 | 84.7 (82.8, 86.4) | 11 | 1 (haematuria) |
| Kidney | 1695 | 63.9 (61.6, 66.1) | 26 | 0 |
| Ureteric and other urinary | 275 | 80.0 (74.9, 84.3) | 19 | 0 |
| Haematological | ||||
| Acute leukaemia | 471 | 72.0 (67.8, 75.8) | 27 | 0 |
| Chronic lymphocytic leukaemia | 529 | 47.6 (43.4, 51.9) | 16 | 0 |
| Hodgkin lymphoma | 243 | 86.0 (81.1, 89.8) | 23 | 0 |
| Multiple myeloma | 904 | 66.6 (63.5, 69.6) | 19 | 0 |
| Non-Hodgkin lymphoma | 2055 | 78.1 (76.3, 79.8) | 30 | 0 |
| Other haematological | 588 | 61.2 (57.2, 65.1) | 26 | 0 |
| Central nervous system (CNS) | ||||
| CNS | 777 | 78.6 (75.6, 81.4) | 9 | 0 |
| Sarcoma | ||||
| Bone sarcoma | 63 | 79.4 (67.8, 87.5) | 15 | 0 |
| Connective and soft tissue sarcoma | 372 | 86.0 (82.1, 89.2) | 26 | 0 |
| Skin | ||||
| Melanoma | 2790 | 91.8 (90.7, 92.8) | 6 | 1 (abnormal mole) |
| Ocular | ||||
| Ocular | 111 | 40.5 (31.9, 49.8) | 2 | 0 |
| Breast | ||||
| Breast | 6166 | 91.8 (91.1, 92.5) | 7 | 1 (breast lump/mass) |
| Gynaecological | ||||
| Cervix | 252 | 86.9 (82.2, 90.5) | 20 | 0 |
| Ovary | 1174 | 86.7 (84.7, 88.5) | 27 | 0 |
| Uterus | 1572 | 93.2 (91.8, 94.3) | 17 | 1 (post-menopausal bleeding) |
| Vulva/Vagina | 241 | 84.6 (79.6, 88.7) | 14 | 0 |
| Prostate and other male organs | ||||
| Penile | 119 | 86.6 (79.3, 91.6) | 11 | 0 |
| Prostate | 8747 | 70.1 (69.2, 71.1) | 13 | 0 |
| Testicular | 403 | 90.8 (87.6, 93.3) | 6 | 1 (testicular lump) |
| Other malignant neoplasms | ||||
| Other malignant neoplasms | 190 | 69.5 (62.6, 75.6) | 35 | 0 |
| Unknown primary | ||||
| Unknown primary | 1205 | 79.2 (76.8, 81.4) | 28 | 0 |